independent.co.ug13h
Uganda rolls out Ebola Sudan trial vaccine for high-risk populations
Kampala, Uganda | THE INDEPENDENT | The Ministry of Health has started rolling out the Ebola Sudan Trial Vaccine to high-risk ...
STAT1d
Pharmalittle: We’re reading about tariffs’ effect on drug costs, a scrapped vaccine plant expansion, and more
This would reverse progress toward curbing drug shortages. AstraZeneca scrapped plans to invest $558.3 million in its vaccine ...
CNBC Africa1d
Can Africa Fill Its Own Prescription?
Africa’s pharmaceutical future is at a critical juncture with developments shedding light on the continent’s reliance on external aid for vaccine access. The Trump administration’s initial freeze on ...
Moscow-Pullman Daily News4d
New bill introduced to put 10-year pause on certain vaccines
BOISE — Sen. Brandon Shippy, R-New Plymouth, is proposing to put a 10-year pause on certain types of vaccines that were used ...
Pharm Exec5d
Roundup: Top Pharma Companies Report Q4 Earnings, Highlighting Revenue Trends and Market Shifts
Q4 earnings for companies such as Johnson & Johnson, Teva, and Roche highlight the impact of significant innovations brought ...
Is Johnson & Johnson (JNJ) the Safe Stock to Buy for the Long Term in 2025?
We recently published a list of 12 Safe Stocks to Buy for the Long Term in 2025. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other safe stocks to ...
IISc researchers working on anti-virals for mosquito-borne diseases
BENGALURU: Vaccines and antiviral, although not very effective are there for flu virus, however there are none which are clinically approved for mosquito borne ...